[1] [1] GUNNARSSON M, MOJUMDAR E H, TOPGAARD D,et al. Extraction of natural moisturizing factor from thestratum corneumand its implication on skin molecular mobility [J]. Journal of Colloid and Interface Science, 2021, 604: 480-491.

[2] [2] OHNARI H, NARU E J, SAKATA O,et al. Distribution of domains formed by lateral packing of intercellular lipid in thestratum corneum[J]. Chemical & Pharmaceutical Bulletin, 2023, 71(1): 31-40.

[3] [3] SHETAGE S S, TRAYNOR M J, BROWN M B,et al. Effect of ethnicity, gender and age on the amount and composition of residual skin surface components derived from sebum, sweat and epidermal lipids [J]. Skin Research and Technology, 2014, 20(1): 97-107.

[4] [4] PROKSCH E, BRANDNER J M, JENSEN J M. The skin: an indispensable barrier [J]. Experimental Dermatology, 2008, 17(12): 1063-1072.

[5] [5] LUEBBERDING S, KRUEGER N, KERSCHER M. Age-related changes in skin barrier function: quantitative evaluation of 150 female subjects [J]. International Journal of Cosmetic Science, 2013, 35(2): 183-190.

[6] [6] HORNBY S, WALTERS R, TIERNEY N,et al. Effect of commercial cleansers on skin barrier permeability [J]. Skin Research and Technology, 2016, 22(2): 196-202.

[7] [7] JURAKI TONI R, MARINOVI B. The role of impaired epidermal barrier function in atopic dermatitis [J]. Acta Dermatovenerologica Croatica, 2016, 24(2): 95-109.

[8] [8] THAWER-ESMAI F. Skin barrier function and atopic eczema[J]. Current Allergy & Clinical Immunology, 2011, 24(4): 193-211.

[9] [9] LAMBERS H, PIESSENS S, BLOEM A,et al. Natural skin surface pH is on average below 5, which is beneficial for its resident flora [J]. International Journal of Cosmetic Science, 2006, 28(5): 359-370.

[10] [10] SCHMID-WENDTNER M H, KORTING H C. The pH of the skin surface and its impact on the barrier function [J]. Skin Pharmacology and Physiology, 2006, 19(6): 296-302.

[11] [11] DE BENEDETTO A, AGNIHOTHRI R, MCGIRT L Y,et al. Atopic dermatitis: a disease caused by innate immune defects?[J]. Journal of Investigative Dermatology, 2009, 129(1): 14-30.

[12] [12] SKABYTSKA Y, KAESLER S, VOLZ T,et al. The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments [J]. Seminars in Immunopathology, 2016, 38(1): 29-43.

[13] [13] GALLO R L, HOOPER L V. Epithelial antimicrobial defence of the skin and intestine [J]. Nature Reviews. Immunology, 2012, 12(7): 503-516.

[14] [14] TAGAMI H. Location-related differences in structure and function of thestratum corneumwith special emphasis on those of the facial skin [J]. International Journal of Cosmetic Science, 2008, 30(6): 413-434.

[15] [15] CANDI E, SCHMIDT R, MELINO G. The cornified envelope: a model of cell death in the skin [J]. Nature Reviews. Molecular Cell Biology, 2005, 6(4): 328-340.

[16] [16] LIN T K, CRUMRINE D, ACKERMAN L D,et al. Cellular changes that accompany shedding of human corneocytes [J]. Journal of Investigative Dermatology, 2012, 132(10): 2430-2439.

[17] [17] KATAGIRI C, SATO J, NOMURA J,et al. Changes in environmental humidity affect the water-holding property of thestratum corneumand its free amino acid content, and the expression of filaggrin in the epidermis of hairless mice [J]. Journal of Dermatological Science, 2003, 31(1): 29-35.

[18] [18] JANSSENS M, VAN SMEDEN J, GOORIS G S,et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients [J]. Journal of Lipid Research, 2012, 53(12): 2755-2766.

[19] [19] SANDILANDS A, SUTHERLAND C, IRVINE A D,et al. Filaggrin in the frontline: role in skin barrier function and disease [J]. Journal of Cell Science, 2009, 122(Pt 9): 1285-1294.

[20] [20] KENNETH HOOBER J, EGGINK L L. The discovery and function of filaggrin [J]. International Journal of Molecular Sciences, 2022, 23(3): 1455.

[21] [21] THYSSEN J P, KEZIC S. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis[J]. Journal of Allergy and Clinical Immunology, 2014, 134(4): 792-799.

[22] [22] ANGELOVA-FISCHER I, MANNHEIMER A C, HINDER A,et al. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling [J]. Experimental Dermatology, 2011, 20(4): 351-356.

[23] [23] KEZIC S, KEMPERMAN P M J H, KOSTER E S,et al. Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in thestratum corneum[J]. The Journal of Investigative Dermatology, 2008, 128(8): 2117-2119.

[24] [24] DANBY S G, CORK M J. The effects of pimecrolimus on the innate immune response in atopic dermatitis [J]. British Journal of Dermatology, 2013, 168(2): 235-236.

[25] [25] LUEBBERDING S, KRUEGER N, KERSCHER M. Skin physiology in men and women:in vivoevaluation of 300 people including TEWL, SC hydration, sebum content and skin surface pH [J]. International Journal of Cosmetic Science, 2013, 35(5): 477-483.

[26] [26] RIPPKE F, SCHREINER V, SCHWANITZ H J. The acidic milieu of the horny layer: new findings on the physiology and pathophysiology of skin pH [J]. American Journal of Clinical Dermatology, 2002, 3(4): 261-272.

[27] [27] CHITTOCK J, COOKE A, LAVENDER T,et al. Development ofstratum corneumchymotrypsin-like protease activity and natural moisturizing factors from birth to 4 weeks of age compared with adults [J]. British Journal of Dermatology, 2016, 175(4): 713-720.

[28] [28] STAMATAS G N, NIKOLOVSKI J, MACK M C,et al. Infant skin physiology and development during the first years of life: a review of recent findings based onin vivostudies [J]. International Journal of Cosmetic Science, 2011, 33(1): 17-24.

[29] [29] FLUHR J W, DARLENSKI R, LACHMANN N,et al. Infant epidermal skin physiology: adaptation after birth [J]. British Journal of Dermatology, 2012, 166(3): 483-490.

[30] [30] KOTTNER J, LICHTERFELD A, BLUME-PEYTAVI U. Maintaining skin integrity in the aged: a systematic review [J]. British Journal of Dermatology, 2013, 169(3): 528-542.

[31] [31] CHU M, KOLLIAS N. Documentation of normalstratum corneumscaling in an average population: features of differences among age, ethnicity and body site [J]. British Journal of Dermatology, 2011, 164(3): 497-507.

[32] [32] CHALYK N E, BANDALETOVA T Y, KYLE N H,et al. Age-related differences in morphological characteristics of residual skin surface components collected from the surface of facial skin of healthy male volunteers [J]. Skin Research and Technology, 2017, 23(2): 212-220.

[33] [33] TTH B I, OLH A, SZLLOSI A G,et al. “Sebocytes’makeup”: novel mechanisms and concepts in the physiology of the human sebaceous glands [J]. Pflugers Archiv, 2011, 461(6): 593-606.

[34] [34] BOIREAU-ADAMEZYK E, BAILLET-GUFFROY A, STAMATAS G N. Age-dependent changes instratum corneumbarrier function [J]. Skin Research and Technology, 2014, 20(4): 409-415.

[35] [35] GUINOT C, MALVY D, AMBROISINE L,et al. Effect of hormonal replacement therapy on skin biophysical properties of menopausal women [J]. Skin Research and Technology, 2005, 11(3): 201-204.

[36] [36] BRINCAT M, MUSCAT BARON Y, GALEA R. Estrogens and the skin [J]. Climacteric, 2005, 8(2): 110-123.

[37] [37] ZOUBOULIS C, CHEN W C, THORNTON M,et al. Sexual hormones in human skin [J]. Hormone and Metabolic Research, 2007, 39(2): 85-95.

[38] [38] PAUL C, MAUMUS-ROBERT S, MAZEREEUW-HAUTIER J,et al. Prevalence and risk factors for xerosis in the elderly: a cross-sectional epidemiological study in primary care [J]. Dermatology, 2011, 223(3): 260-265.

[39] [39] GRUNDMANN S A, STNDER S. Evaluation of chronic pruritus in older patients [J]. Aging Health, 2010, 6(1): 53-66.

[40] [40] FARAGE M A, MILLER K W, BERARDESCA E,et al. Clinical implications of aging skin: cutaneous disorders in the elderly [J]. American Journal of Clinical Dermatology, 2009, 10(2): 73-86.

[41] [41] LEBLANC K, BARANOSKI S, MEMBERS S T C P. Skin tears: state of the science: consensus statements for the prevention, prediction, assessment, and treatment of skin tears?[J]. Advances in Skin & Wound Care, 2011, 24(Suppl 9): 2-15.

[42] [42] ROBINSON H, JARRETT P, BROADBENT E. The effects of relaxation before or after skin damage on skin barrier recovery: a preliminary study [J]. Psychosomatic Medicine, 2015, 77(8): 844-852.

[43] [43] SUGIYAMA A, FUJITA Y, KOBAYASHI T,et al. Effect of protein malnutrition on the skin epidermis of hairless mice [J]. Journal of Veterinary Medical Science, 2011, 73(6): 831-835.

[44] [44] WOJTOWICZ-PRUS E, KILIS-PSTRUSINSKA K, REICH A,et al. Disturbed skin barrier in children with chronic kidney disease [J]. Pediatric Nephrology, 2015, 30(2): 333-338.

[45] [45] SEIRAFI H, FARSINEJAD K, FIROOZ A,et al. Biophysical characteristics of skin in diabetes: a controlled study [J]. Journal of the European Academy of Dermatology and Venereology, 2009, 23(2): 146-149.

[46] [46] SPADA F, BARNES T M, GREIVE K A. Skin hydration is significantly increased by a cream formulated to mimic the skin’s own natural moisturizing systems [J]. Clinical, Cosmetic and Investigational Dermatology, 2018, 11: 491-497.

[47] [47] PURNAMAWATI S, INDRASTUTI N, DANARTI R,et al. The role of moisturizers in addressing various kinds of dermatitis: a review [J]. Clinical Medicine & Research, 2017, 15(3/4): 75-87.

[48] [48] DRAELOS Z D. Modern moisturizer myths, misconceptions, and truths [J]. Cutis, 2013, 91(6): 308-314.

[49] [49] SPADA F, HARRISON I P, BARNES T M,et al. A daily regimen of a ceramide-dominant moisturizing cream and cleanser restores the skin permeability barrier in adults with moderate eczema: a randomized trial [J]. Dermatologic Therapy, 2021, 34(4): e14970.

[50] [50] PROKSCH E, BERARDESCA E, MISERY L,et al. Dry skin management: practical approach in light of latest research on skin structure and function [J]. Journal of Dermatological Treatment, 2020, 31(7): 716-722.

[51] [51] SANTOS-CAETANO J P, VILA P, GFELLER C F,et al. Cosmetic use of three topical moisturizers following glycolic acid facial peels [J]. Journal of Cosmetic Dermatology, 2020, 19(3): 660-670.

[52] [52] EBERLEIN B, EICKE C, REINHARDT H W,et al. Adjuvant treatment of atopic eczema: assessment of an emollient containingN-palmitoylethanolamine (ATOPA study) [J]. Journal of the European Academy of Dermatology and Venereology, 2008, 22(1): 73-82.

[53] [53] KEMENY L, KORECK A, KIS K,et al. Endogenous phospholipid metabolite containing topical product inhibits ultraviolet light-induced inflammation and DNA damage in human skin [J]. Skin Pharmacology and Physiology, 2007, 20(3): 155-161.

[54] [54] KIM J M, KIM W I, KO H C,et al. Epidermal barrier function changes after ablative and non-ablative fractional laser administration [J]. Journal of the European Academy of Dermatology and Venereology, 2017, 31(2): e83-e85.

[55] [55] NISBET S J. Skin acceptability of a cosmetic moisturizer formulation in female subjects with sensitive skin [J]. Clinical, Cosmetic and Investigational Dermatology, 2018, 11: 213-217.

[56] [56] YUAN C, WANG X M, GUICHARD A,et al.N-palmitoylethanolamine andN-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients [J]. Clinical Interventions in Aging, 2014, 9: 1163-1169.

[57] [57] FLEISCHER D M, UDKOFF J, BOROK J,et al. Atopic dermatitis: skin care and topical therapies [J]. Seminars in Cutaneous Medicine and Surgery, 2017, 36(3): 104-110.

[58] [58] SZEPIETOWSKI J C, SZEPIETOWSKI T, REICH A. Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study [J]. Acta Dermatovenerologica Croatica, 2005, 13(2): 97-103.